These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6677656)

  • 41. Prevention by thioethers of the hepatotoxicity and covalent binding to macromolecules of N-hydroxy-2-acetylaminofluorene and its sulfate ester in rat liver in vivo and in vitro.
    van den Goorbergh JA; de Wit H; Tijdens RB; Mulder GJ; Meerman JH
    Carcinogenesis; 1987 Feb; 8(2):275-9. PubMed ID: 2433070
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolism and binding of benzo(a)pyrene and 2-acetylaminofluorene by short-term organ cultures of human and rat bladder.
    Moore BP; Hicks RM; Knowles MA; Redgrave S
    Cancer Res; 1982 Feb; 42(2):642-8. PubMed ID: 6275985
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Age-related changes in mutagen activation by rat tissues.
    Robertson IG; Birnbaum LS
    Chem Biol Interact; 1982 Jan; 38(2):243-52. PubMed ID: 6799214
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells.
    Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS
    Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of the persistently bound form of the carcinogen N-acetyl-2-aminofluorene to rat liver DNA in vivo.
    Westra JG; Kriek E; Hittenhausen H
    Chem Biol Interact; 1976 Oct; 15(2):149-64. PubMed ID: 975399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of glutathione levels, sulfate levels, and metabolic inhibitors on covalent binding of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-acetylaminofluorene to cell macromolecules in primary monolayer cultures of adult rat hepatocytes.
    Loretz LJ; Pariza MW
    Carcinogenesis; 1984 Jul; 5(7):895-9. PubMed ID: 6428766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolism of 2-acetylaminofluorene by hepatocytes isolated from rainbow trout.
    Steward AR; Elmarakby SA; Stuart KG; Kumar S; Sikka HC
    Toxicol Appl Pharmacol; 1995 Feb; 130(2):188-96. PubMed ID: 7871532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Requirement for metabolic activation of acetylaminofluorene to induce multidrug gene expression.
    Gant TW; Schrenk D; Silverman JA; Thorgeirsson SS
    Environ Health Perspect; 1994 Oct; 102 Suppl 6(Suppl 6):209-12. PubMed ID: 7889850
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolism of 2-acetylaminofluorene in primary rat hepatocyte cultures.
    Spilman SD; Byard JL
    J Toxicol Environ Health; 1981 Jan; 7(1):93-106. PubMed ID: 7265302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-sulfoöxy-2-aminofluorene is the major ultimate electrophilic and carcinogenic metabolite of N-hydroxy-2-acetylaminofluorene in the livers of infant male C57BL/6J x C3H/HeJ F1 (B6C3F1) mice.
    Lai CC; Miller JA; Miller EC; Liem A
    Carcinogenesis; 1985 Jul; 6(7):1037-45. PubMed ID: 3860305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes.
    McManus ME; Boobis AR; Minchin RF; Schwartz DM; Murray S; Davies DS; Thorgeirsson SS
    Cancer Res; 1984 Dec; 44(12 Pt 1):5692-7. PubMed ID: 6498831
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction, activation, and inhibition of hamster and rat liver microsomal arylamide and arylamine N-hydroxylase.
    Razzouk C; Mercier M; Roberfroid M
    Cancer Res; 1980 Oct; 40(10):3540-6. PubMed ID: 7438040
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of ellagic acid by oral administration on distribution and metabolism of 2-aminofluorene in Sprague-Dawley rats.
    Ho CC; Lai YS; Wang DY; Chen YS; Lee JH; Tang NI; Chung JG
    In Vivo; 2005; 19(1):143-56. PubMed ID: 15796167
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of acetylator genotype on hepatic and extrahepatic acetylation, deacetylation, and sulfation of 2-aminofluorene, 2-acetylaminofluorene, and N-hydroxy-2-acetylaminofluorene in the inbred hamster.
    Hein DW; Kirlin WG; Ogolla F; Trinidad A; Thompson LK; Ferguson RJ
    Drug Metab Dispos; 1986; 14(5):566-73. PubMed ID: 2876863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Suppressive role of indole on 2-acetylaminofluorene hepatotoxicity.
    Hopp ML; Matsumoto M; Wendell B; Lee C; Oyasu R
    Cancer Res; 1976 Jan; 36(1):234-9. PubMed ID: 1248002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Teratogenicity in vitro of two deacetylated metabolites of N-hydroxy-2-acetylaminofluorene.
    Faustman-Watts EM; Greenaway JC; Namkung MJ; Fantel AG; Juchau MR
    Toxicol Appl Pharmacol; 1984 Oct; 76(1):161-71. PubMed ID: 6484986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Catechin inhibition of mutagenesis and alteration of DNA binding of 2-acetyl-aminofluorene in rat hepatocytes.
    Monteith DK
    Mutat Res; 1990 Feb; 240(2):151-8. PubMed ID: 2405265
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolism of 2-acetylaminofluorene in cultured human lymphocytes.
    McManus ME; Trainor KJ; Morley AA; Burgess W; Stupans I; Birkett DJ
    Res Commun Chem Pathol Pharmacol; 1987 Mar; 55(3):409-18. PubMed ID: 3575877
    [TBL] [Abstract][Full Text] [Related]  

  • 60. N-acetyltransferase multiplicity and the bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes.
    Smith TJ; Hanna PE
    Carcinogenesis; 1986 May; 7(5):697-702. PubMed ID: 3486051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.